Freis and his team continued to run clinical trials late in to his career, assessing the newer hypertension drugs as they were developed. In this article, they reported that an early trial on nitrendipine, a calcium channel blocker, indicated that it was an effective antihypertensive agent with minor side-effects.
Copyright:
The National Library of Medicine believes this item to be in the public domain. (More information)
